OptiBiotix Health Plc（OPBXF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · OPBXF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2018-11	2017-11
Revenue
Revenue	$0.46M	$2.21M	$1.52M	$0.51M	$0.19M
Cost of Revenue	$0.21M	$1.09M	$0.64M	$0.16M	$0.07M
Gross Profit	$0.24M	$1.12M	$0.88M	$0.35M	$0.12M
Gross Margin %(computed)	53.39%	50.76%	57.76%	68.35%	61.43%
Operating Expenses
R&D Expenses	$0.07M	$0.06M	$0.09M	$0.16M	$0.30M
G&A Expenses	$0.83M	$0.93M	$0.74M	$1.58M	$2.24M
Total Operating Expenses	$10.76M	$2.49M	$1.99M	$1.85M	$2.24M
Operating Income	($2.49M)	($1.37M)	($1.11M)	($1.50M)	($2.13M)
Operating Margin %(computed)	-544.64%	-61.70%	-72.96%	-291.45%	—
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$0.00M	$0.05M	$0.04M	$0.00M	$0.01M
Income Before Tax	$2.44M	$6.18M	$5.71M	($1.95M)	$1.69M
Income Tax Expense	($0.15M)	($0.08M)	($0.09M)	($0.05M)	($0.23M)
Net Income	$2.59M	$6.26M	$5.80M	($1.92M)	$1.91M
Net Margin %(computed)	566.08%	282.93%	380.89%	-373.19%	998.28%
Per Share & EBITDA
EPS (Basic)	$0.03	$0.07	$0.07	$-0.02	$0.02
Wtd Avg Shares	93.21M	95.54M	95.57M	82.23M	78.59M
EBITDA	($10.38M)	$6.51M	$6.00M	($1.81M)	($2.42M)
EBITDA Margin %(computed)	—	294.30%	394.10%	-350.98%	—